artemisinin has been researched along with Leukemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Ackermann, L; Belyakova, YY; Çapcı, A; Dheeraj, A; Herrmann, L; Hodek, J; Malhotra, SV; Radulov, PS; Struwe, J; Tailor, D; Terent'ev, AO; Tsogoeva, SB; Weber, J; Yaremenko, IA | 1 |
| Hristova-Avakumova, NG; Momekov, GT; Zhelyazkova, MY | 1 |
| Chen, H; Cui, J; Dai, T; Lin, L; Liu, Y; Lu, W; Sun, D; Yang, L; Yang, X | 1 |
| Arav-Boger, R; Chen, X; Civin, CI; Fox, JM; He, R; Mott, BT; Posner, GH | 1 |
| Lai, HC; Park, J; Sasaki, T; Singh, M; Singh, NP | 1 |
| Bahsi, H; Efferth, T; Friedrich, O; Fröhlich, T; Hampel, F; Kappes, B; Leidenberger, M; Marschall, M; Reiter, C; Tsogoeva, SB; Zeino, M | 1 |
| Kim, BJ; Lai, H; Oh, S; Sasaki, T; Singh, NP | 1 |
7 other study(ies) available for artemisinin and Leukemia
| Article | Year |
|---|---|
Synthesis and in vitro Study of Artemisinin/Synthetic Peroxide-Based Hybrid Compounds against SARS-CoV-2 and Cancer.
Topics: Animals; Antiviral Agents; Artemisinins; Chlorocebus aethiops; COVID-19 Drug Treatment; Humans; Leukemia; Neoplasms; Peroxides; Quinolines; SARS-CoV-2; Vero Cells | 2022 |
Antitumor activity of the combination of artemisinin and epirubicin in human leukemia cells.
Topics: Anthracyclines; Artemisinins; Deoxyribose; Doxorubicin; Drug Synergism; Epirubicin; Humans; Iron; Lecithins; Leukemia | 2021 |
Novel nitrogen mustard-artemisinin hybrids with potent anti-leukemia action through DNA damage and activation of GPx.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Cell Line, Tumor; DNA Damage; Glutathione Peroxidase; Humans; Leukemia; Mechlorethamine; Neoplasms | 2022 |
Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity study.
Topics: Antineoplastic Agents; Antiviral Agents; Artemisinins; Cytomegalovirus; Cytomegalovirus Infections; Dimerization; Esters; Humans; Jurkat Cells; Leukemia; Phosphates | 2013 |
Development of a dihydroartemisinin-resistant Molt-4 leukemia cell line.
Topics: Antimalarials; Artemisinins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Leukemia; Transferrin; Tumor Cells, Cultured | 2014 |
New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids.
Topics: Artemisinins; Cell Line, Tumor; Drug Resistance, Multiple; Ferrous Compounds; Heterocyclic Compounds; Heterocyclic Compounds, 4 or More Rings; Humans; Inhibitory Concentration 50; Leukemia; Metallocenes; Plasmodium falciparum | 2015 |
Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide.
Topics: Antineoplastic Agents; Artemisia; Artemisinins; Cells, Cultured; Humans; Leukemia; Leukocytes; Peptide Fragments; Receptors, Transferrin; Recombinant Fusion Proteins; Transferrin | 2009 |